Cargando…
Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512274/ https://www.ncbi.nlm.nih.gov/pubmed/36174596 http://dx.doi.org/10.1016/S1473-3099(22)00592-8 |
| _version_ | 1784797815621287936 |
|---|---|
| author | Nichols, Russell M Deveau, Carmen Upadhyaya, Himanshu |
| author_facet | Nichols, Russell M Deveau, Carmen Upadhyaya, Himanshu |
| author_sort | Nichols, Russell M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9512274 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95122742022-09-27 Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic Nichols, Russell M Deveau, Carmen Upadhyaya, Himanshu Lancet Infect Dis Correspondence Elsevier Ltd. 2022-11 2022-09-26 /pmc/articles/PMC9512274/ /pubmed/36174596 http://dx.doi.org/10.1016/S1473-3099(22)00592-8 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Nichols, Russell M Deveau, Carmen Upadhyaya, Himanshu Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic |
| title | Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic |
| title_full | Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic |
| title_fullStr | Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic |
| title_full_unstemmed | Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic |
| title_short | Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic |
| title_sort | bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512274/ https://www.ncbi.nlm.nih.gov/pubmed/36174596 http://dx.doi.org/10.1016/S1473-3099(22)00592-8 |
| work_keys_str_mv | AT nicholsrussellm bebtelovimabconsiderationsforglobalaccesstotreatmentsduringarapidlyevolvingpandemic AT deveaucarmen bebtelovimabconsiderationsforglobalaccesstotreatmentsduringarapidlyevolvingpandemic AT upadhyayahimanshu bebtelovimabconsiderationsforglobalaccesstotreatmentsduringarapidlyevolvingpandemic |